menu ☰
menu ˟

FDA grants orphan drug status to Glassia for GVHD

29 Oct 2014
The FDA granted orphan drug designation to a liquid alpha-1 proteinase inhibitor for the treatment of patients with graft-versus-host disease following allogeneic bone marrow stem cell transplant, its manufacturer announced recently.Based on preclini...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.